Lv5
962 积分 2022-11-07 加入
Betulinic acid induces lysosome-dependent death in prostate cancer by targeting DDX5
5小时前
待确认
Therapy-induced APOBEC3A drives evolution of persistent cancer cells
1个月前
已完结
Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse
1个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
1个月前
已完结
APOBEC3A drives resistance
2个月前
已完结
Acquired resistance in cancer: towards targeted therapeutic strategies
2个月前
已完结
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2个月前
已完结
Cancer drug resistance: an evolving paradigm
2个月前
已完结
Emerging insights into lineage plasticity in pancreatic cancer initiation, progression, and therapy resistance
2个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
2个月前
已完结
皖公网安备34019202002308
